Shivangi Shrimali

Researcher

National Center for Toxicological Research

unknown

2 h-index 4 pubs 13 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Shivangi Shrimali's research investigates the mechanisms of radioprotection and radiomitigation, with a focus on the role of tocotrienols and their analogues. Her work has explored how these compounds provide protection to various organ systems through antioxidant and signaling pathways. Shrimali has also contributed to the evaluation of new approach methodologies (NAMs) for assessing drug-induced liver injury (DILI) and the use of microphysiological systems for drug absorption, distribution, metabolism, excretion, and toxicity studies. She has collaborated with researchers from the University of Arkansas for Medical Sciences, including Philip J. Breen and Darin E. Jones, on multiple publications. Shrimali's scholarship metrics include an h-index of 2 and 13 total citations across 4 publications.

Metrics

  • h-index: 2
  • Publications: 4
  • Citations: 13

Selected Publications

  • Microphysiological systems as an emerging in vitro approach for the evaluation of drug absorption, distribution, metabolism, and excretion and toxicity (2025) DOI
  • New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now? (2025) DOI
  • Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects (2023) DOI
  • 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator (2023) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics